Cargando…

Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

Objective: To examine whether joint management of cancer pain by physicians and pharmacists in clinics provides economic advantages from the perspective of the Chinese healthcare system. Methods: From February 2018 to March 2020, 100 patients who visited the joint cancer pain clinic at the Xiangya H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Xikui, Zhang, Lu, Huang, Hangxing, Wu, Xiangping, Wang, Zhenting, Huang, Ling, Li, Jingyang, Yu, Huimin, Zhang, Hongyan, Xiao, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436594/ https://www.ncbi.nlm.nih.gov/pubmed/37601047 http://dx.doi.org/10.3389/fphar.2023.1073939

Ejemplares similares

Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis
por: Lu, Xikui, et al.
Publicado: (2023)

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China
por: Guo, Chengxian, et al.
Publicado: (2021)

Evaluating clinical pharmacists’ involvement in postoperative acute pain services: a multicenter survey in Guangdong Province, China
por: Lu, Junxiong, et al.
Publicado: (2023)

Analysis of patient medication compliance and quality of life of physician-pharmacist collaborative clinics for T2DM management in primary healthcare in China: A mixed-methods study
por: Xiao, Jie, et al.
Publicado: (2023)

Perceptions, Expectations, and Experience of Physicians About Pharmacists and Pharmaceutical Care Services in Pakistan: Findings and Implications
por: Hayat, Khezar, et al.
Publicado: (2021)

Pharmacists and family physicians: improving interprofessional collaboration through joint understanding of our competencies
por: Stringer, Katherine, et al.
Publicado: (2013)

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone
por: Satsuma, Yukari, et al.
Publicado: (2020)

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate
por: Ramos, Hernán, et al.
Publicado: (2021)

Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
por: Qiu, Sha, et al.
Publicado: (2021)

Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study
por: Xu, Huimin, et al.
Publicado: (2019)

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
por: Luo, Rui, et al.
Publicado: (2023)

The Impact of Clinical Pharmacist Implemented Protocol on Albumin Utilization and Cost in an Intensive Care Unit in Egypt
por: Ibrahim, Dina Mohamed, et al.
Publicado: (2022)

A cost-effectiveness analysis of an in-hospital clinical pharmacist service
por: Wallerstedt, Susanna M, et al.
Publicado: (2012)

Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial
por: Schumacher, Pia M., et al.
Publicado: (2021)

Physicians’ Knowledge, Altitudes, and Perceived Barriers of Inappropriate Prescribing for Older Patients in Shanghai, China
por: Yuan, Jing, et al.
Publicado: (2022)

The Clinical Pharmacist-Led Consultation for Infectious Diseases in Guizhou Province, China: A Survey Among Hospital Pharmacies
por: Zhang, Jiaxing, et al.
Publicado: (2020)

Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross‐Sectional Study
por: Hu, Wen, et al.
Publicado: (2022)

Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development
por: Wang, Na, et al.
Publicado: (2021)

Berberine Facilitates Extinction and Prevents the Return of Fear
por: Huang, Shihao, et al.
Publicado: (2022)

The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis
por: Yang, Si, et al.
Publicado: (2020)

Economic burden of opioid misuse focused on direct medical costs
por: Kim, Miryoung, et al.
Publicado: (2022)

The Effectiveness of Clinical Pharmacist-Led Consultation in the Treatment of Infectious Diseases: A Prospective, Multicenter, Cohort Study
por: Zhang, Jiaxing, et al.
Publicado: (2020)

Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare
por: Lu, Z. Kevin, et al.
Publicado: (2021)

Factors influencing clinical pharmacists’ integration into the clinical multidisciplinary care team
por: Wang, Chenyu, et al.
Publicado: (2023)

Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015–2017 Years
por: Mela, Aneta, et al.
Publicado: (2020)

Insulin degludec/liraglutide versus its monotherapy on T2D patients: A lifetime cost-utility analysis in China
por: Han, Guangxin, et al.
Publicado: (2022)

Association of pharmaceutical care barriers and role ambiguity and role conflict of clinical pharmacists
por: Sun, Qingran, et al.
Publicado: (2023)

The Physician and the Pharmacist
Publicado: (1955)

Physicians and Pharmacists
Publicado: (1882)

Does China’s competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine
por: Zhang, Chao, et al.
Publicado: (2023)

SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
por: Lu, He, et al.
Publicado: (2023)

Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
por: He, Yumei, et al.
Publicado: (2023)

Defining and supporting a professional role for pharmacists associated with traditional and complementary medicines: a cross-country survey of pharmacists
por: Harnett, Joanna E., et al.
Publicado: (2023)

Treatment for Severe Lupus Nephritis: A Cost-Effectiveness Analysis in China
por: Dai, Zonglin, et al.
Publicado: (2021)

Pharmacist-led iodinated contrast media infusion risk assessment service
por: Jiang, Huiyan, et al.
Publicado: (2023)

Molecular Epidemiology of and Risk Factors for Extensively Drug-Resistant Klebsiella pneumoniae Infections in Southwestern China: A Retrospective Study
por: Tian, Xiaolang, et al.
Publicado: (2019)

Antimicrobial Stewardship Programs in Northwest China: A Cross-Sectional Survey of Perceptions, Involvement, and Perceived Barriers Among Hospital Pharmacists
por: Ji, Wenjing, et al.
Publicado: (2021)

Medication Choices in Children With Tic Disorders in Mainland China, Macao, Hong Kong, and Taiwan: Perspectives of Guardians and Physicians
por: Yang, Chunsong, et al.
Publicado: (2022)

Development of the Practice of Pharmaceutical Care for Cancer Pain Management in Outpatient Clinics Using the Delphi Method
por: Zhang, Lu, et al.
Publicado: (2022)

Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial
por: Zhang, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rnjmrg51ka5sqrh45j1rv3hdc